{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:14:28Z","timestamp":1793139268706,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82071810"],"award-info":[{"award-number":["No. 82071810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Natural Science Foundation of Zhejiang Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Abnormal activation of synovial fibroblasts (SFs) plays an important role in rheumatoid arthritis (RA), the mechanism of which remains unknown. The purpose of our study is to comprehensively and systematically explore the mechanism for Semaphorin 5A-mediated abnormal SF activation in RA. Here, we found that Semaphorin 5A levels were significantly higher in synovial fluid and synovial tissue from RA patients compared with osteoarthritis patients. We further found that the mRNA level and protein abundance of Plexin-A1 was elevated in RA SFs compared with OA SFs, while Plexin-B3 expression showed no significant difference. The increased Semaphorin 5A in RA synovial fluid was mainly derived from CD68\n                    <jats:sup>+<\/jats:sup>\n                    synovial macrophages, and the elevation led to increased binding between Semaphorin 5A and its receptors, thereby promoting cytokine secretion, proliferation, and migration, and decreasing apoptosis. Moreover, the effect of Semaphorin 5A on enhancing activation (cytokine secretion, cell proliferation and migration) and reducing apoptosis of SFs was significantly abolished after knockdown of Plexin-A1 and Plexin-B3 by small interfering RNA. Transcriptome sequencing and protein array detection revealed that Semaphorin 5A activated the PI3K\/AKT\/mTOR signaling pathway and inhibited ferroptosis. Morphologically, transmission electron microscopy results showed that Semaphorin 5A could significantly eliminate the mitochondrial diminution, membrane density increased and crest ruptured of SFs induced by ferroptosis inducer RSL3. Mechanistically, Semaphorin 5A enhanced GPX4 expression and SREBP1\/SCD-1 signaling by activating the PI3K\/AKT\/mTOR signaling pathway, thus suppressing ferroptosis of RA SFs. In conclusion, our study provided the first evidence that elevated Semaphorin 5A in RA synovial fluid promotes SF activation by suppressing ferroptosis through the PI3K\/AKT\/mTOR signaling pathway.\n                  <\/jats:p>","DOI":"10.1038\/s41419-022-05065-4","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T05:05:04Z","timestamp":1657775104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":139,"title":["Semaphorin 5A suppresses ferroptosis through activation of PI3K-AKT-mTOR signaling in rheumatoid arthritis"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0720-3188","authenticated-orcid":false,"given":"Qi","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-7519","authenticated-orcid":false,"given":"Huaxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-4197","authenticated-orcid":false,"given":"Yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"5065_CR1","doi-asserted-by":"publisher","first-page":"Itc1","DOI":"10.7326\/AITC201901010","volume":"170","author":"JA Sparks","year":"2019","unstructured":"Sparks JA. Rheumatoid arthritis. Ann Intern Med. 2019;170:Itc1\u201316.","journal-title":"Ann Intern Med"},{"key":"5065_CR2","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41584-018-0112-7","volume":"14","author":"SG Dakin","year":"2018","unstructured":"Dakin SG, Coles M, Sherlock JP, Powrie F, Carr AJ, Buckley CD. Pathogenic stromal cells as therapeutic targets in joint inflammation. Nat Rev Rheumatol. 2018;14:714\u201326.","journal-title":"Nat Rev Rheumatol"},{"key":"5065_CR3","doi-asserted-by":"crossref","unstructured":"Kuo D, Ding J, Cohn IS, Zhang F, Wei K, Rao DA, et al. HBEGF(+) macrophages in rheumatoid arthritis induce fibroblast invasiveness. Sci Transl Med. 2019;11:eaau8587.","DOI":"10.1126\/scitranslmed.aau8587"},{"key":"5065_CR4","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1002\/art.25020","volume":"60","author":"Y Take","year":"2009","unstructured":"Take Y, Nakata K, Hashimoto J, Tsuboi H, Nishimoto N, Ochi T, et al. Specifically modified osteopontin in rheumatoid arthritis fibroblast-like synoviocytes supports interaction with B cells and enhances production of interleukin-6. Arthritis Rheum. 2009;60:3591\u2013601.","journal-title":"Arthritis Rheum"},{"key":"5065_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrrheum.2017.201","volume":"14","author":"M Nishide","year":"2018","unstructured":"Nishide M, Kumanogoh A. The role of semaphorins in immune responses and autoimmune rheumatic diseases. Nat Rev Rheumatol. 2018;14:19\u201331.","journal-title":"Nat Rev Rheumatol"},{"key":"5065_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/cei.12924","volume":"188","author":"Y Du","year":"2017","unstructured":"Du Y, Wu X, Chen M, Wang W, Xv W, Ye L, et al. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis. Clin Exp Immunol. 2017;188:234\u201342.","journal-title":"Clin Exp Immunol"},{"key":"5065_CR7","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/art.38425","volume":"66","author":"C Gras","year":"2014","unstructured":"Gras C, Eiz-Vesper B, Jaimes Y, Immenschuh S, Jacobs R, Witte T, et al. Secreted semaphorin 5A activates immune effector cells and is a biomarker for rheumatoid arthritis. Arthritis Rheumatol. 2014;66:1461\u201371.","journal-title":"Arthritis Rheumatol"},{"key":"5065_CR8","first-page":"661","volume":"57","author":"Y Du","year":"2018","unstructured":"Du Y, Wang JW, Zhou MJ, Wu XY, Xue J, Wu HX. [The expression of Semaphorin 5A in patients with rheumatoid arthritis and its effect on osteoclastogenesis]. Zhonghua Nei Ke za Zhi. 2018;57:661\u20136.","journal-title":"Zhonghua Nei Ke za Zhi"},{"key":"5065_CR9","doi-asserted-by":"crossref","unstructured":"Xiao C, Lv C, Sun S, Zhao H, Ling H, Li M, et al. TSP1 is the essential domain of SEMA5A involved in pannus formation in rheumatoid arthritis. Rheumatology (Oxford). 2021;60:5833\u201342.","DOI":"10.1093\/rheumatology\/keab133"},{"key":"5065_CR10","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/art.40504","volume":"70","author":"J Falconer","year":"2018","unstructured":"Falconer J, Murphy AN, Young SP, Clark AR, Tiziani S, Guma M, et al. Review: synovial cell metabolism and chronic inflammation in rheumatoid arthritis. Arthritis Rheumatol. 2018;70:984\u201399.","journal-title":"Arthritis Rheumatol"},{"key":"5065_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/art.38190","volume":"66","author":"M Kato","year":"2014","unstructured":"Kato M, Ospelt C, Gay RE, Gay S, Klein K. Dual role of autophagy in stress-induced cell death in rheumatoid arthritis synovial fibroblasts. Arthritis Rheumatol. 2014;66:40\u20138.","journal-title":"Arthritis Rheumatol"},{"key":"5065_CR12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"5065_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41590-021-00993-3","volume":"22","author":"P Li","year":"2021","unstructured":"Li P, Jiang M, Li K, Li H, Zhou Y, Xiao X, et al. Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity. Nat Immunol. 2021;22:1107\u201317.","journal-title":"Nat Immunol"},{"key":"5065_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.neuron.2011.06.009","volume":"71","author":"RL Matsuoka","year":"2011","unstructured":"Matsuoka RL, Chivatakarn O, Badea TC, Samuels IS, Cahill H, Katayama K, et al. Class 5 transmembrane semaphorins control selective Mammalian retinal lamination and function. Neuron. 2011;71:460\u201373.","journal-title":"Neuron"},{"key":"5065_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/sj.embor.7400189","volume":"5","author":"S Artigiani","year":"2004","unstructured":"Artigiani S, Conrotto P, Fazzari P, Gilestro GF, Barberis D, Giordano S, et al. Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep. 2004;5:710\u20134.","journal-title":"EMBO Rep"},{"key":"5065_CR16","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","volume":"20","author":"F Zhang","year":"2019","unstructured":"Zhang F, Wei K, Slowikowski K, Fonseka CY, Rao DA, Kelly S, et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol. 2019;20:928\u201342.","journal-title":"Nat Immunol"},{"key":"5065_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng J, Conrad M. The metabolic underpinnings of ferroptosis. Cell Metab. 2020;32:920\u201337.","journal-title":"Cell Metab"},{"key":"5065_CR18","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi J, Zhu J, Wu J, Thompson CB, Jiang X. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci USA. 2020;117:31189\u201397.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5065_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21841-w","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Swanda RV, Nie L, Liu X, Wang C, Lee H, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun. 2021;12:1589.","journal-title":"Nat Commun"},{"key":"5065_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/art.40406","volume":"70","author":"S You","year":"2018","unstructured":"You S, Koh JH, Leng L, Kim WU, Bucala R. The tumor-like phenotype of rheumatoid synovium: molecular profiling and prospects for precision medicine. Arthritis Rheumatol. 2018;70:637\u201352.","journal-title":"Arthritis Rheumatol"},{"key":"5065_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 2020;16:316\u201333.","journal-title":"Nat Rev Rheumatol"},{"key":"5065_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunological Rev. 2010;233:233\u201355.","journal-title":"Immunological Rev"},{"key":"5065_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mvr.2009.10.005","volume":"79","author":"A Sadanandam","year":"2010","unstructured":"Sadanandam A, Rosenbaugh EG, Singh S, Varney M, Singh RK. Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis. Microvasc Res. 2010;79:1\u20139.","journal-title":"Microvasc Res"},{"key":"5065_CR24","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s10620-013-2666-1","volume":"58","author":"G Pan","year":"2013","unstructured":"Pan G, Zhu Z, Huang J, Yang C, Yang Y, Wang Y, et al. Semaphorin 5A promotes gastric cancer invasion\/metastasis via urokinase-type plasminogen activator\/phosphoinositide 3-kinase\/protein kinase B. Digestive Dis Sci. 2013;58:2197\u2013204.","journal-title":"Digestive Dis Sci"},{"key":"5065_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27948-4","volume":"13","author":"J Wu","year":"2022","unstructured":"Wu J, Feng Z, Chen L, Li Y, Bian H, Geng J, et al. TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models. Nat Commun. 2022;13:676.","journal-title":"Nat Commun"},{"key":"5065_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrrheum.2016.91","volume":"12","author":"IA Udalova","year":"2016","unstructured":"Udalova IA, Mantovani A, Feldmann M. Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol. 2016;12:472\u201385.","journal-title":"Nat Rev Rheumatol"},{"key":"5065_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41586-019-1471-1","volume":"572","author":"S Culemann","year":"2019","unstructured":"Culemann S, Gr\u00fcneboom A, Nicol\u00e1s-\u00c1vila J, Weidner D, L\u00e4mmle KF, Rothe T, et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature. 2019;572:670\u20135.","journal-title":"Nature"},{"key":"5065_CR28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1158\/1541-7786.MCR-18-0055","volume":"16","author":"YS Lee","year":"2018","unstructured":"Lee YS, Lee DH, Choudry HA, Bartlett DL, Lee YJ. Ferroptosis-induced endoplasmic reticulum stress: cross-talk between ferroptosis and apoptosis. Mol Cancer Res: MCR. 2018;16:1073\u20136.","journal-title":"Mol Cancer Res: MCR"},{"key":"5065_CR29","doi-asserted-by":"publisher","first-page":"779585","DOI":"10.3389\/fimmu.2022.779585","volume":"13","author":"T Zhao","year":"2022","unstructured":"Zhao T, Yang Q, Xi Y, Xie Z, Shen J, Li Z, et al. Ferroptosis in rheumatoid arthritis: a potential therapeutic strategy. Front Immunol. 2022;13:779585.","journal-title":"Front Immunol"},{"key":"5065_CR30","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569\u201381.","journal-title":"Arthritis Rheum"},{"key":"5065_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum"}],"updated-by":[{"DOI":"10.1038\/s41419-023-05697-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05065-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05065-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05065-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T03:05:08Z","timestamp":1678849508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05065-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["5065"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05065-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-023-05697-0","URL":"https:\/\/doi.org\/10.1038\/s41419-023-05697-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Our study was approved by the Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (approval number: 2020-306). All participants signed a written informed consent form. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"608"}}